[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100447158":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":18,"locations":27,"responsibleParty":44,"collaborators":10,"id":46,"slug":10,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":10,"maxAge":10,"enrollmentInfo":53,"targetDuration":10,"studyType":56,"phases":10,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":30,"whyStopped":10,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"Rigshospitalet, Denmark","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Anoctaminopathies",null,"Anoctaminopathies including Limb Girdle Muscular Dystrophy R12, Miyoshi distal Muscular Dystrophy type 3 and asymptomatic hyperCKemia",[13],"Other: No intervention",[15],{"type":6,"name":16,"description":16,"armGroupLabels":17,"otherNames":10},"No intervention",[9],[19,24],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Nanna S Poulsen, MD","CONTACT","+4535454346","Nanna.scharff.poulsen@regionh.dk",{"name":25,"role":21,"phone":10,"phoneExt":10,"email":26},"John Vissing, MD, DMSc","john.vissing@regionh.dk",[28],{"facility":29,"status":30,"city":31,"state":10,"zip":32,"country":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Nanna Scharff Poulsen","RECRUITING","Copenhagen","2100","Denmark",{"type":35,"coordinates":36},"Point",[37,38],12.56553,55.67594,{"lat":38,"lon":37},[41,42],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},{"name":20,"role":43,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":43,"investigatorFullName":29,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Principal investigator","100447158",false,"NCT05102799","MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants","ANO5 MRI","Inclusion Criteria:\n\n* Two pathogenic variants in the anoctamin-5 gene\n* T1-weighted MR-images of lower back and leg muscles.\n\nExclusion Criteria:\n\n\\- Concomitant other disorders that also can result in muscular atrophy, i.e. polyneuropathy, other muscle diseases, recent long-term stay in intensive care, among others.","ALL",{"count":54,"type":55},200,"ESTIMATED","OBSERVATIONAL","A large cohort of MRI scans from patients with pathogenic variants in the anoctamin 5 gene will be collected through an international collaboration to better describe muscle involvement.",[59],"Limb Girdle Muscular Dystrophy",[61],"Anoctaminophathies","2025-04-02",{"date":64,"type":65},"2025-04-06","ACTUAL",{"date":67,"type":65},"2021-04-01",{"date":69,"type":55},"2026-08-01",{"name":5,"class":6},1]